| 产品详情 |
| Edit |   |
|---|
| Product Name | GSK-503 |
|---|
| Description | MW: 526.67. Purity ≥98% by HPLC. GSK-503 is a potent EZH2 inhibitor with potential anticancer activity. Increased activity of the epigenetic modifier EZH2 has been associated with different cancers. In a melanoma mouse model; conditional Ezh2 ablation as much as treatment with the preclinical EZH2 inhibitor GSK503 stabilizes the disease through inhibition of growth and virtually abolishes metastases formation without affecting normal melanocyte biology. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [N- ( (4; 6-dimethyl-2-oxo-1; 2-dihydropyridin-3-yl) methyl)-1-isopropyl-3-methyl-6- (6- (4-methylpiperazin-1-yl) pyridin-3-yl)-1H-indole-4-carboxamide] |
|---|
| Gene, Accession, CAS # | CAS: 1346572-63-1 |
|---|
| Catalog # | MBS845720 |
|---|
| Price | |
|---|
| Order / More Info | GSK-503 from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|